We've just witnessed the fall of an ASX dividend aristocrat

Ramsay Health Care Limited (ASX: RHC) is now out of the running to be an ASX dividend aristocrat, at least until 2046. Here's why.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Over in the US, the term 'dividend aristocrat' is one that every investor knows.

It refers to a dividend-paying share that has increased said dividend non-stop for at least 25 years in a row.

Here in Australia, the term is less well known. Why? Because (as hard as it is to believe here in the land of franking credits) we simply don't have any.

And dividend kings – the stocks with a 50-year history of dividend raises? Nothing more than a regal legend on the ASX boards.

However, we do have some ASX shares that are getting close to true 'dividend aristocrat' status.

Take Washington H. Soul Pattinson and Co Ltd (ASX: SOL). Soul Patts has just increased its dividend for the 20th year in a row. 5 more and it will be crowned the ASX's first dividend aristocrat.

Unfortunately, this week, we lost another contender.

Ramsay Health Care Limited (ASX: RHC) had a dividend history to rival that of Soul Patts – delivering a dividend increase annually since 2000.

Until Monday.

ASX dividend aristocrat no more

Tragically, Ramsay will be starting from zero in 2021 after it announced its dividends will be suspended for the remainder of 2020.

The company has already paid an interim dividend in March. But if it doesn't pay a final dividend in 2020 (like it's told us it won't) the 20-year streak will come to an end.

Now, Ramsay must have broken its streak because it absolutely had to. We can gather from the ASX release (in which a capital raising was also announced) that its current cash flows have been so severely impacted by the coronavirus that there simply isn't the money there to fund dividend payments for ordinary shares.

But still, this is a sad week for Ramsay Health Care and its shareholders. The list of potential ASX dividend aristocrats grows thin indeed. After Ramsay, I'm watching Brickworks Limited (ASX: BKW) in this space. It's not far behind Soul Patts for dividend longevity. But who knows, maybe in 2046 Ramsay Health Care might finally wear that coveted crown.

Foolish takeaway

Even though I'm bitterly disappointed about this news from Ramsay, I'm still bullish on the long-term future of this company. It has a large network of impeccably-run private hospitals, both in Australia and across several other countries.

Healthcare is an 'evergreen' industry that will only benefit from the ageing population demographics across advanced economies well into the future.

Motley Fool contributor Sebastian Bowen owns shares of Ramsay Health Care Limited and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia owns shares of and has recommended Brickworks and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Telix shares fall despite 'significant milestone'

Let's see what the biotech has announced on Monday.

Read more »

A male doctor wearing a white doctor's coat shrugs and holds his hands up to indicate the unimpressive CSL share price as a result of OOVID-19
Healthcare Shares

Here's the earnings forecast out to 2030 for CSL shares

How healthy will the profit growth be in the coming years?

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

Shot of a senior scientist looking stressed out while working in a lab.
Healthcare Shares

After soaring 40% in 2 weeks, this ASX All Ords healthcare stock has been downgraded

Here’s what analysts at Macquarie rate the stock as now.

Read more »

A little boy, soon to be a brother, kisses and holds his mum's pregnant tummy.
Healthcare Shares

Own NIB shares? Here are the key dates for 2026

NIB has released its corporate calendar, including dividend dates, for 2026.

Read more »

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused
Healthcare Shares

ASX healthcare stock debuts at a massive discount to its initial public offer price

Saluda Medical shares have had a difficult start to public life, trading well below the initial public offer price.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Healthcare Shares

Why CSL shares now look 'massively oversold'

A leading investment expert says ASX investors have a rare chance to buy CSL shares at a discount.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Which junior biotech's shares are flying on positive trial news?

This company's shares have surged higher after positive clinical trial results for its stroke treatment drug.

Read more »